Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Other 1

Conditions

Obesity 92Overweight 35Neoplasms 32Breast Neoplasms 23Sexual Dysfunction, Physiological 19Dyspnea 15Weight Loss 12Motor Activity 12Endometrial Neoplasms 11Polycystic Ovary Syndrome 10Mucositis 8Diabetes Mellitus, Type 2 8Diabetes Mellitus 8Obesity-Related Malignant Neoplasm 7Hypertension 7Depression 7Anxiety Disorders 7Pediatric Obesity 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Sexual Dysfunctions, Psychological 5Obesity, Morbid 5Lung Neoplasms 5Leukemia 5Endometrial Hyperplasia 5Disease 5Constipation 5Sedentary Behavior 4Pulmonary Disease, Chronic Obstructive 4Prostatic Neoplasms 4

Interventions

Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Progesterone Resistance × Other × 1 year × Clear all
NCT06379113 2025-08-11

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Fudan University

Phase 2/3 Recruiting
29 enrolled
GynecologicOther

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡